Morgan Stanley »

Capstone Therapeutics Corporat shares owned by Morgan Stanley

Quarter-by-quarter ownership of Capstone Therapeutics Corporat (CAPS) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Capstone Therapeutics Corporat

Tip: Access up to 7 years of quarterly data

All positions including Capstone Therapeutics Corporat held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capstone Therapeutics Corporat by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2025-06-30 $2 1 2.00

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Morgan Stanley

Top funds holding Capstone Therapeutics Corporat

Pensionmark Financial Group
Citadel Advisors
Two Sigma Securities
Two Sigma Investments
Tower Research Capital
UBS Group
Morgan Stanley

View all funds holding Capstone Therapeutics Corporat